Photodynamic effect of protoporphyrin IX in gliosarcoma 9l/lacZ cell line

Photodiagnosis Photodyn Ther. 2022 Mar:37:102669. doi: 10.1016/j.pdpdt.2021.102669. Epub 2021 Dec 2.

Abstract

Photodynamic Therapy (PDT) is an oncologic treatment, producing reactive oxygen species (ROS) to induce the death of cancer cells. This study aimed to evaluate the action of PDT on gliosarcoma cells, using protoporphyrin IX as PS by incubation with the precursor aminolevulinic acid (ALA). An LED device was used with a light dose of 10 J/cm². The success of the therapy proved to be dependent on the concentration of ALA, and an incubation time of 4 h required for an effective response. Cell death was prevalent due to necrosis when assessed 18 h post-PDT. ALA proved to be an option to PDT in cells of the 9 L/lacZ, with the protocol tested.

Keywords: 5-ALA; Aminolevulinic acid; Brain cancer; Gliosarcoma; Photodynamic therapy.

MeSH terms

  • Aminolevulinic Acid / pharmacology
  • Aminolevulinic Acid / therapeutic use
  • Cell Line, Tumor
  • Gliosarcoma* / drug therapy
  • Humans
  • Lac Operon
  • Photochemotherapy* / methods
  • Photosensitizing Agents / pharmacology
  • Photosensitizing Agents / therapeutic use
  • Protoporphyrins / pharmacology

Substances

  • Photosensitizing Agents
  • Protoporphyrins
  • Aminolevulinic Acid
  • protoporphyrin IX